摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-D-Lys(Boc)-OH p-nitrophenyl ester | 2592-19-0

中文名称
——
中文别名
——
英文名称
Boc-D-Lys(Boc)-OH p-nitrophenyl ester
英文别名
N-Boc-N'-Boc-D-lysine-4-nitrophenyl ester;Boc-D-lys (Boc)-ONp;4-Nitrophenyl N2,N6-bis(tert-butoxycarbonyl)-D-lysinate;(4-nitrophenyl) (2R)-2,6-bis[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate
Boc-D-Lys(Boc)-OH p-nitrophenyl ester化学式
CAS
2592-19-0
化学式
C22H33N3O8
mdl
——
分子量
467.519
InChiKey
LYUXBTAUKJETMS-QGZVFWFLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    617.0±55.0 °C(Predicted)
  • 密度:
    1.183
  • 溶解度:
    溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    33
  • 可旋转键数:
    13
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    149
  • 氢给体数:
    2
  • 氢受体数:
    8

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    -15°C

SDS

SDS:d7bc3553efd0c785d9890e1a6a86b8ed
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Boc-D-Lys(Boc)-OH p-nitrophenyl ester 在 Cu(II)(2,6-bis(6-monoamino-β-cyclodextrinmethyl)pyridine) 作用下, 以 乙腈 为溶剂, 生成 N2,N6-双-Boc-D-赖氨酸
    参考文献:
    名称:
    配备双(β-环糊精)的非手性铜配合物对氨基酸酯的对映选择性水解
    摘要:
    摘要 研究了两种配备双(β-环糊精) (bisCDs) 的非手性铜 (II) 配合物作为水解酶模型,用于两对具有烷基链的氨基酸酯对映异构体的对映选择性水解。两种 bisCD 配合物以不同的 CD 空腔取向吡啶连接,表示为 CuL 1 ( L 1 = 2,6-bis(6-mono-amino-β-cyclodextrin-methyl)-pyridine) 和 CuL 2 ( L 2 = 2,6-双(3-单氨基-β-环糊精-甲基)-吡啶)。动力学研究表明,与“面对面”bisCD 复合物 CuL 2 相比,“背对背”bisCD 复合物 CuL 1 对所有底物显示出更高的催化效率和更显着的对映选择性。观察到两种复合物的 L-异构体的总体偏好。在 CuL 1 的存在下,通过饱和动力学研究和电喷雾电离质谱(ESI-MS)分析证明了水解过程中催化剂-底物米氏络合物的形成。N-Boc-N'-Boc-赖氨酸
    DOI:
    10.1016/j.molcata.2016.09.009
  • 作为产物:
    参考文献:
    名称:
    10.2174/0115701786284263240219080226
    摘要:
    Abstract: Impurities are an integral part of drug substances, even though they have not been studied in the pharmacological evaluation of the Benefit-Risk (BR) profiles. Hence, understanding their origin and controlling them have prime importance during drug substance development. The structures of some of the impurities in lisdexamfetamine dimesylate, a central nervous system stimulant drug, have been confirmed based on literature and analytical data. The study has been undertaken to evaluate impurities arising from oxidative degradation and impurities due to material attributes. All the listed impurities have been identified, synthesized, and characterized by spectral tools. We have, herein, reported the synthesis of two oxidative degradant impurities, 2-hydroxylisdexamfetamine dimesylate and 4-hydroxylisdexafetamine dimesylate. In addition, chiral isomeric impurities of lisdexamfetamine dimesylate as (S,R), (R,S) and (R,R)-lisdexamfetamine dimesylate have also been reported. These impurities have been identified and synthesized, and a control strategy for mitigating risk in lisdexamfetamine dimesylate is provided.
    DOI:
    10.2174/0115701786284263240219080226
点击查看最新优质反应信息

文献信息

  • Lysine–spermine conjugates: hydrophobic polyamine amides as potent lipopolysaccharide sequestrants
    作者:Mark R. Burns、Stewart J. Wood、Kelly A. Miller、Thuan Nguyen、Jens R. Cromer、Sunil A. David
    DOI:10.1016/j.bmc.2005.01.038
    日期:2005.4
    Lipopolysaccharides (LPS), otherwise termed `endotoxins' are outer-membrane constituents of Gram-negative bacteria. Lipopolysaccharides play a key role in the pathogenesis of `Septic Shock', a major cause of mortality in the critically ill patient. Therapeutic options aimed at limiting downstream systemic inflammatory processes by targeting lipopolysaccharide do not exist at the present time. We have defined the pharmacophore necessary for small molecules to specifically bind and neutralize LPS and, using animal models of sepsis, have shown that the sequestration of circulatory LPS by small molecules is a therapeutically viable strategy. In this paper, the interactions of a focused library of lysine-spermine conjugates with lipopolysaccharide (LPS) have been characterized. Lysine-spermine conjugates with the epsilon-amino terminus of the lysinyl moiety derivatized with long-chain aliphatic hydrophobic substituents in acyl or alkyl linkage bind and neutralize bacterial lipopolysaccharides, and may be of use in the prevention or treatment of endotoxic shock states. (c) 2005 Elsevier Ltd. All rights reserved.
  • Enantioselective hydrolysis of amino acid esters by non-chiral copper complexes equipped with bis (β-cyclodextrin)s
    作者:Shan-Shan Xue、Meng Zhao、Jing-Xing Lan、Rui-Rong Ye、Yi Li、Liang-Nian Ji、Zong-Wan Mao
    DOI:10.1016/j.molcata.2016.09.009
    日期:2016.12
    Abstract Two non-chiral copper(II) complexes equipped with bis(β-cyclodextrin)s (bisCDs) were explored as hydrolase models for the enantioselective hydrolysis of two pairs of alkyl chain-possessing amino acid ester enantiomers. The two bisCD complexes are pyridine-linked with different CD cavity orientations, denoted as CuL 1 ( L 1  = 2,6-bis(6-mono-amino-β-cyclodextrin-methyl)-pyridine) and CuL 2
    摘要 研究了两种配备双(β-环糊精) (bisCDs) 的非手性铜 (II) 配合物作为水解酶模型,用于两对具有烷基链的氨基酸酯对映异构体的对映选择性水解。两种 bisCD 配合物以不同的 CD 空腔取向吡啶连接,表示为 CuL 1 ( L 1 = 2,6-bis(6-mono-amino-β-cyclodextrin-methyl)-pyridine) 和 CuL 2 ( L 2 = 2,6-双(3-单氨基-β-环糊精-甲基)-吡啶)。动力学研究表明,与“面对面”bisCD 复合物 CuL 2 相比,“背对背”bisCD 复合物 CuL 1 对所有底物显示出更高的催化效率和更显着的对映选择性。观察到两种复合物的 L-异构体的总体偏好。在 CuL 1 的存在下,通过饱和动力学研究和电喷雾电离质谱(ESI-MS)分析证明了水解过程中催化剂-底物米氏络合物的形成。N-Boc-N'-Boc-赖氨酸
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物